Recent years have witnessed remarkable developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://emilylckk570160.timeblog.net/74728500/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements